© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
November 07, 2022
A session presenter at the ASCP 2022 Annual Meeting explained how patients’ mismanagement of medications for headaches can lead to rebound headaches.
A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Session presenters at ASCP 2022 Annual Meeting discuss the benefits and disadvantages of apixaban versus warfarin for anticoagulation.
A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.
November 06, 2022
American Society of Consultant Pharmacists executive director and CEO explained how staffing struggles in long-term care facilities can be an opportunity for pharmacists to expand the ways they provide support beyond immunizations alone.
Beth Macy, author of New York Times-bestselling book Dopesick and executive producer and writer on the Hulu series “Dopesick,” explains how FDA-approved drugs that treat opioid use disorder still aren’t getting into the hands of patients who need it most.
November 01, 2022
An ASCP 2022 Annual Meeting session presenter provides an update of 6 new therapeutic agents and their appropriate use in an older adult population.
October 31, 2022
Pharmacy Times will be covering the American Society of Consultant Pharmacists (ASCP) Annual Meeting, which will be gathering senior care pharmacists in San Antonio, Texas.
October 27, 2022
ASCP 2022 session presenters review the evidence that tipped the scales against the use of aspirin for primary prevention in patients aged 60 years or older.
October 26, 2022
ASCP 2022 session presenters discuss medications that can cause QTc prolongation, with a particular emphasis on a review of the literature with regards to QTc prolongation and antipsychotics.